IDNA vs. VOO
IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) and VOO (Vanguard S&P 500 ETF) are both exchange-traded funds - IDNA is a Health & Biotech Equities fund tracking the NYSE FactSet Global Genomics and Immuno Biopharma Index, while VOO is a S&P 500 fund tracking the S&P 500 Index. Both are passively managed. Over the past 5 years, IDNA returned -8.26%/yr vs 14.26%/yr for VOO. A 0.57 correlation means they provide meaningful diversification when combined. IDNA charges 0.47%/yr vs 0.03%/yr for VOO.
Performance
IDNA vs. VOO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IDNA achieves a 9.51% return, which is significantly lower than VOO's 11.69% return.
IDNA
- 1D
- -2.18%
- 1M
- -2.18%
- YTD
- 9.51%
- 6M
- 10.53%
- 1Y
- 41.74%
- 3Y*
- 6.48%
- 5Y*
- -8.26%
- 10Y*
- —
VOO
- 1D
- 0.14%
- 1M
- 5.39%
- YTD
- 11.69%
- 6M
- 12.11%
- 1Y
- 29.68%
- 3Y*
- 22.73%
- 5Y*
- 14.26%
- 10Y*
- 15.65%
IDNA vs. VOO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 9.51% | 17.26% | -0.72% | -7.63% | -42.28% | -3.98% | 54.30% | 20.83% |
VOO Vanguard S&P 500 ETF | 11.69% | 17.82% | 24.98% | 26.32% | -18.17% | 28.79% | 18.32% | 12.85% |
Correlation
The correlation between IDNA and VOO is 0.55, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.55 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.54 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.58 |
Correlation (All Time) Calculated using the full available price history since Jun 14, 2019 | 0.57 |
The correlation between IDNA and VOO has been stable across timeframes, ranging from 0.54 to 0.58 - a consistent structural relationship.
IDNA vs. VOO - Sectors Allocation Comparison
Sectors
IDNA
VOO
Healthcare
Industrials
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
IDNA
VOO
Industrials
IDNA
VOO
Basic Materials
IDNA
-
VOO
Communication Services
IDNA
-
VOO
Consumer Cyclical
IDNA
-
VOO
Consumer Defensive
IDNA
-
VOO
Energy
IDNA
-
VOO
Financial Services
IDNA
-
VOO
Real Estate
IDNA
-
VOO
Technology
IDNA
-
VOO
Utilities
IDNA
-
VOO
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDNA vs. VOO — Risk / Return Rank
IDNA
VOO
IDNA vs. VOO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IDNA | VOO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.71 | 2.53 | -0.82 |
Sortino ratioReturn per unit of downside risk | 2.48 | 3.43 | -0.95 |
Omega ratioGain probability vs. loss probability | 1.28 | 1.46 | -0.18 |
Calmar ratioReturn relative to maximum drawdown | 4.09 | 3.42 | +0.67 |
Martin ratioReturn relative to average drawdown | 11.79 | 15.95 | -4.16 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IDNA | VOO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.71 | 2.53 | -0.82 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.29 | 0.85 | -1.15 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.87 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.10 | 0.89 | -0.79 |
Drawdowns
IDNA vs. VOO - Drawdown Comparison
The maximum IDNA drawdown since its inception was -68.26%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for IDNA and VOO.
Loading charts...
Drawdown Indicators
| IDNA | VOO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.26% | -33.99% | -34.27% |
Max Drawdown (1Y)Largest decline over 1 year | -10.66% | -8.90% | -1.76% |
Max Drawdown (3Y)Largest decline over 3 years | -29.73% | -18.69% | -11.04% |
Max Drawdown (5Y)Largest decline over 5 years | -68.26% | -24.52% | -43.74% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.99% | — |
Current DrawdownCurrent decline from peak | -46.01% | 0.00% | -46.01% |
Average DrawdownAverage peak-to-trough decline | -36.24% | -3.69% | -32.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.70% | 1.91% | +1.79% |
Volatility
IDNA vs. VOO - Volatility Comparison
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a higher volatility of 7.24% compared to Vanguard S&P 500 ETF (VOO) at 2.74%. This indicates that IDNA's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IDNA | VOO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.24% | 2.74% | +4.50% |
Volatility (6M)Calculated over the trailing 6-month period | 18.21% | 8.88% | +9.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.51% | 11.78% | +12.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.42% | 16.81% | +11.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.53% | 18.01% | +11.52% |
IDNA vs. VOO - Expense Ratio Comparison
IDNA has a 0.47% expense ratio, which is higher than VOO's 0.03% expense ratio.
Dividends
IDNA vs. VOO - Dividend Comparison
IDNA's dividend yield for the trailing twelve months is around 1.08%, more than VOO's 1.02% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.08% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% | 0.00% | 0.00% | 0.00% | 0.00% |
VOO Vanguard S&P 500 ETF | 1.02% | 1.13% | 1.24% | 1.46% | 1.69% | 1.25% | 1.54% | 1.88% | 2.06% | 1.78% | 2.02% | 2.10% |
Frequently Asked Questions
IDNA and VOO have a correlation of 0.55, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDNA has higher volatility (7.24%) compared to VOO (2.74%). In terms of maximum drawdown, IDNA dropped -68.26% vs VOO's -33.99%.
On 5-year performance, VOO leads with 14.26% vs -8.26% for IDNA. On fees, VOO is cheaper at 0.03% per year. On volatility, VOO has been the lower-risk option at 2.74%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, VOO has performed better with a 14.26% return vs -8.26%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
VOO is cheaper with a 0.03% expense ratio, compared with 0.47% for IDNA.
IDNA has the higher dividend yield at 1.08%, compared with 1.02% for VOO.
IDNA is categorized as Health & Biotech Equities, while VOO is S&P 500. IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index, while VOO tracks S&P 500 Index. They also come from different issuers: iShares and Vanguard. Their fees differ too: 0.47% for IDNA and 0.03% for VOO.
VOO currently has the higher Sharpe Ratio (2.53 vs 1.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IDNA and VOO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer